Benoît Ranchoux

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods

Inference and analysis of cell-cell communication using CellChat

Pulmonary veno-occlusive disease

Wnt5a is elevated in heart failure and affects cardiac fibroblast function

Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease

Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease

Updated Clinical Classification of Pulmonary Hypertension

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

The role of chemokines and chemokine receptors in pulmonary arterial hypertension

miR-223 reverses experimental pulmonary arterial hypertension

Nebivolol for Improving Endothelial Dysfunction, Pulmonary Vascular Remodeling, and Right Heart Function in Pulmonary Hypertension

Chemotherapy-Induced Pulmonary Hypertension

DNA Damage and Pulmonary Hypertension

Mitomycin-Induced Pulmonary Veno-Occlusive Disease